Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.3700 (-0.83%) ($8.3700 - $8.4900) on Fri. Sep. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 44 | Latest Price | $8.3700(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(72%) XBI(71%) ARKK(60%) IBB(60%) IBUY(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.28% in a week (0% probabilities). EDOC(-26%) TBT(-25%) UUP(-15%) VXX(-11%) VIXM(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.83 | 5 Day Moving Average | $8.68(-3.57%) | 10 Day Moving Average | $8.82(-5.1%) | 20 Day Moving Average | $8.83(-5.21%) | To recent high | -9.8% | To recent low | 4.6% | Market Cap | $520m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |